[Subjective aspects of pharmacotherapy in schizophrenia during implementation of chlorpromazine in Poland--a review].
Introduction of chlorpromazine was the breakthrough in psychiatric practice. Pharmacotherapy with chlorpromazine started in Polish hospitals in the autumn and winter in 1954 and the first papers covering clinical experiences started to be published in 1955. Some of these papers are very informative about subjective aspects of pharmacotherapy, comparison of older and new method of treatment, changes of psychiatric wards atmosphere. They inform also about some social aspects of introduction of this new drug to the practice. In the example families were involved in gaining the drugs for ill family members and doctors sometimes had to win persons' in charge consent to start treatment. In this papers the hope that patients treated with the new drug are more prone to psychotherapy have been expressed. This kind of hope is now expressed in regard to the second generation of antipsychotics. The paper of a Polish author published 1969 that is the pioneering work in the field of research of subjective aspects of pharmacotherapy is presented. Conclusions and methodology of this study are very similar to the later studies that were published in psychiatric literature at the end of 1970's.
Murawiec
Sławomir
S
D014150:Antipsychotic Agents / Q000592:standards / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000592:standards / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000592:standards; D011044:Poland; D011785:Quality Assurance, Health Care / Q000592:standards; D012107:Research Design / Q000592:standards; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D002746:Chlorpromazine